| 标题 |
Final progression-free survival, interim overall survival, and biomarker analyses of CHOICE-01: A phase 3 study of toripalimab versus placebo in combination with first-line chemotherapy for advanced NSCLC without EGFR/ALK mutations |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Clinical Oncology 作者:Jie Wang; Zhijie Wang; Lin Wu; Baolan Li; Ying Cheng; et al 出版日期:2022-06-07 |
| 求助人 | |
| 下载 |
xiaobaiyang
Lv4 求助人 发起了本次求助
PDF的下载单位、IP信息已删除
(2025-6-4)